Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)

Merck Sharp & Dohme LLC · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
urothelial carcinoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 871322
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.